Patents by Inventor Owen R. White

Owen R. White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Complete genome sequence of the methanogenic archaeon, Methanococcus jannaschii
    Patent number: 6797466
    Abstract: The present application describes the complete 1.66-megabase pair genome sequence of an autotrophic archaeon, Methanococcus jannaschii, and its 58- and 16-kilobase pair extrachromosomal elements. Also described are 1738 predicted protein-coding genes.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: September 28, 2004
    Assignees: The Institute for Genomic Research, Johns Hopkins University, The Board of Trustees of the University of Illinois
    Inventors: Carol J. Bult, Owen R. White, Hamilton O. Smith, Carl R. Woese, J. Craig Venter
  • Nucleotide sequence of the Mycoplasma genitalium genome, fragments thereof, and uses thereof
    Publication number: 20030170663
    Abstract: The present invention provides the nucleotide sequence of the entire genome of Mycoplasma genitalium, SEQ ID NO: 1. The present invention further provides the sequence information stored on computer readable media, and computer-based systems and methods which facilitate its use. In addition to the entire genomic sequence, the present invention identifies protein encoding fragments of the genome, and identifies, by position relative to two (2) genes known to flank the origin of replication, any regulatory elements which modulate the expression of the protein encoding fragments of the Mycoplasma genitalium genome.
    Type: Application
    Filed: July 26, 2002
    Publication date: September 11, 2003
    Applicant: Johns Hopkins University
    Inventors: Claire M. Fraser, Mark D. Adams, Jeannine D. Gocayne, Clyde A. Hutchison, Hamilton O. Smith, J. Craig Venter, Owen R. White
  • Human potassium channel 1 and 2 proteins
    Publication number: 20030092895
    Abstract: Disclosed are human K+ channel polypeptides and DNA (RNA) encoding such K+ channel polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques. Agonists for such K+ channel polypeptides are also disclosed. Such agonists may be used to treat epilepsy, stroke, hypertension, asthma, Parkinson's disease, schizophrenia, anxiety, depression and neurodegeneration. Also disclosed are antagonists against such polypeptides which may be used to treat AIDS, SLE, diabetes, multiple sclerosis and cancer. Also disclosed are diagnostic assays for detecting mutations in the polynucleotide sequences of the present invention.
    Type: Application
    Filed: December 23, 2002
    Publication date: May 15, 2003
    Inventors: Yi Li, Mark D. Adams, Owen R. White
  • Selected polynucleotide and polypeptide sequences of the methanogenic archaeon, methanococcus jannashii
    Patent number: 6503729
    Abstract: The present application describes selected polynucleotide sequence from the 1.66-megabase pair genome sequence of an autotrophic archaeon, Methanococcus jannaschii, and its 58- and 16-kilobase pair extrachromosomal elements.
    Type: Grant
    Filed: August 22, 1997
    Date of Patent: January 7, 2003
    Assignees: The Board of Trustees of the University of Illinois, The Institute for Genomic Research, Johns Hopkins University
    Inventors: Carol J. Bult, Owen R. White, Hamilton O. Smith, Carl R. Woese, J. Craig Venter
  • Human potassium channel 1 and 2 proteins
    Publication number: 20020132775
    Abstract: Disclosed are human K+ channel polypeptides and DNA (RNA) encoding such K+ channel polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques. Agonists for such K+ channel polypeptides are also disclosed. Such agonists may be used to treat epilepsy, stroke, hypertension, asthma, Parkinson's disease, schizophrenia, anxiety, depression and neurodegeneration. Also disclosed are antagonists against such polypeptides which may be used to treat AIDS, SLE, diabetes, multiple sclerosis and cancer. Also disclosed are diagnostic assays for detecting mutations in the polynucleotide sequences of the present invention.
    Type: Application
    Filed: May 13, 2002
    Publication date: September 19, 2002
    Applicant: Human Genome Sciences, Inc.
    Inventors: Yi Li, Mark D. Adams, Owen R. White
  • Human potassium channel 1 and 2 proteins
    Patent number: 5710019
    Abstract: Disclosed are human K.sub.+ channel polypeptides and DNA (RNA) encoding such K.sub.+ channel polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques. Agonists for such K.sub.+ channel polypeptides are also disclosed. Such agonists may be used to treat epilepsy, stroke, hypertension, asthma, Parkinson's disease, schizophrenia, anxiety, depression and neurodegeneration. Also disclosed are antagonists against such polypeptides which may be used to treat AIDS, SLE, diabetes, multiple sclerosis and cancer. Also disclosed are diagnostic assays for detecting mutations in the polynucleotide sequences of the present invention.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 20, 1998
    Assignee: Human Genome Sciences, Inc.
    Inventors: Yi Li, Mark D. Adams, Owen R. White